SYMLIN Pen-injector Devices Now Available
January 07, 2008
Digg This! | Send to Newsvine | Add to del.icio.usSymlinPen Offers SYMLIN Administration for Enhanced Glucose Control with Potential Weight Loss
January 7, 2008 (Press Release) – Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today the availability of the SymlinPen™ 120 and the SymlinPen™ 60 pen-injector devices for administering SYMLIN® (pramlintide acetate) injection. These new pre-filled pen-injector devices feature simple, fixed dosing to improve mealtime glucose control.
“SYMLIN offers enhanced blood glucose control with potential weight loss for patients with diabetes using mealtime insulin, enabling them to do more to manage their diabetes,” said Daniel M. Bradbury, President and CEO, Amylin Pharmaceuticals. “The convenience of the new SymlinPen™ with simple, fixed dosing will make it easier for these patients using multiple daily injections to start and stay with SYMLIN.”
SymlinPen™ 120 features fixed dosing to deliver 60 or 120 micrograms of SYMLIN per dose. SymlinPen™ 60 features fixed dosing to deliver 15, 30, 45, or 60 micrograms of SYMLIN per dose. Both pen-injector devices can be conveniently stored at room temperature not to exceed 86 degrees F (30 degrees C) after first use.
Posted by dlifenews at January 7, 2008 04:44 PM